Companies · Other Health Care

Scientia Vascular, Inc.

WEST VALLEY CITY · Other Health Care

Diligence memoA one-page analyst read on Scientia Vascular, Inc. — recommendation, valuation, rhythm, risks.
$55.0M
Total raised · real
2
Rounds
0.1×
Latest step-up
Top 8%
Sector rank · raised
Series C
Latest stage · inferred · Wed Nov 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Scientia Vascular, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.07× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.
At-risk
  • Last raise 2.6 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Scientia Vascular, Inc. is one of 5376 Other Health Care companies tracked from WEST VALLEY CITY. By capital raised it ranks among the largest (ahead of 93% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(c)
Reg D exemption
29
Investors (latest)
2023-11-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries C · 2021-05-26 Raised $50M (real) Modeled valuation $906M (est)$50M$906MSeries C2021Series C · 2023-11-15 Raised $5.0M (real) Modeled valuation $48M (est)$5.0M$48MSeries C2023+$5.0MCumulative $55M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series C$50.0M · 2021
Series C extension$5.0M · 2023

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.

Modeled valuation trajectory
$48.2M
Base estimate est.
$18.3M
Conservative case
$79.8M
Upside case
$33.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series C · modeled $906.5M · 2021-05-262021Series C · modeled $48.2M · 2023-11-152023
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
2.6 yr
Elapsed time used
2.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
30 mo
Avg between rounds
$22.3M/yr
Capital velocity
5.1 yr
On record since
2021
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 23× above median
This company$55.0M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.1× of median
This company$5.0M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 2.2× above median
This company$48.2M
Sector median$22.1M

Raised more than 93% of sector peers (real $). Modeled value above 66% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #45 of 47.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Gravie, Inc. · Series C Raised $160.7M · modeled $1.3B (est)EmpowerMe Holdings, LLC · Series C Raised $96.6M · modeled $1.3B (est)Color Holdings, L.P. · Series C Raised $90.9M · modeled $1.1B (est)RSR Senior Residences, LLC · Series C Raised $73.7M · modeled $1.1B (est)Gynesonics, Inc · Series C Raised $299.1M · modeled $1.0B (est)Hello Heart Inc. · Series C Raised $127.0M · modeled $1.0B (est)Beta Bionics, Inc · Series C Raised $277.5M · modeled $1.0B (est)BioDerm Holdings, LP · Series C Raised $130.9M · modeled $1.0B (est)Kindbody, Inc. · Series C Raised $95.6M · modeled $874.4M (est)Drconsulta Ltd. · Series C Raised $140.1M · modeled $836.7M (est)Fountain Life, LLC · Series C Raised $103.9M · modeled $827.7M (est)TherapyMatch, Inc. · Series C Raised $100.0M · modeled $808.6M (est)Scientia Vascular, Inc. (this company) Raised $55.0M · modeled $48.2M (est)Scientia Vascular, Inc.
CompanyStageRaised · realValue · estvs peer med.
Gravie, Inc.Series C$160.7M$1.3B2.04×
EmpowerMe Holdings, LLCSeries C$96.6M$1.3B1.92×
Color Holdings, L.P.Series C$90.9M$1.1B1.75×
RSR Senior Residences, LLCSeries C$73.7M$1.1B1.71×
Gynesonics, IncSeries C$299.1M$1.0B1.58×
Hello Heart Inc.Series C$127.0M$1.0B1.54×
Beta Bionics, IncSeries C$277.5M$1.0B1.54×
BioDerm Holdings, LPSeries C$130.9M$1.0B1.53×
Kindbody, Inc.Series C$95.6M$874.4M1.33×
Drconsulta Ltd.Series C$140.1M$836.7M1.28×
Fountain Life, LLCSeries C$103.9M$827.7M1.26×
TherapyMatch, Inc.Series C$100.0M$808.6M1.23×
Scientia Vascular, Inc. this companySeries C$55.0M$48.2M0.07×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series C$50.0M2021-05-26$333.3M$906.5M90%
Series C$5.0M2023-11-15$33.5M$48.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series C$50.0M2021-05-26
    • First recorded raise — entered as Series C.
    • 1 investor on this round.
  2. Series C$5.0M2023-11-15
    • Raised again after 30 mo — slower than the ~14 mo sector norm.
    • Round 10.0× smaller than the prior — bridge or down round.
    • Switched to Rule 506(c) (was Rule 506(b)).
    • 29 investors on this round.
Intelligence
2026 ~Q2
Modeled next raise · ~30mo cadence
$5.0M
Modeled next size est.range $5.0M$8.0M
0.1×
Last step-up
$22.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Bearss4 other2021-05
Mahendra Shah4 other2023-11
Jerry Henley1 other2021-05
Joseph Siletto1 other2023-11
De Lyle Bloomquist2021-05
Huy M. Do2021-05
Janet M. Lowe2023-11
Jeffrey M. Gladden2021-05
John Lippert2021-05
Larry Myres2023-11
Nathan M. Dau2023-11
Rick Randall2021-05
Stacy Lippert2021-05
Registry & provenance

Scientia Vascular, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1866522
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Miach Orthopaedics Inc.Other Health CareSeries C$67.8M$44.0Msame sector · same stage
Transenterix IncOther Health CareSeries C$72.2M$45.7Msame sector · same stage
Preventice Solutions, Inc.Other Health CareSeries D+$275.3M$1.0Bnetwork1 shared operator · same sector
PrognomIQ, Inc.Other Health CareSeries B$56.2M$49.0Msame sector
Practice Fusion IncOther Health CareSeries C$222.5M$57.2Msame sector · same stage
Endostim, Inc.Other Health CareSeries A$61.3M$56.7Msame sector
Homology Medicines, Inc.PharmaceuticalsSeries C$127.1M$2.9Bnetwork1 shared operator · same stage
EarLens CorpOther Health CareSeries C$287.1M$55.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
SciLogica CorpOther Health CareSeries A$9.7M87%
Arterys IncOther Health CareSeries B$540.3M86%
Dragon Vascular, Inc.Other Health CareSeries B$83.2M85%
SonoVascular, Inc.Other Health CareSeed$28.8M85%
Neuro-Vascular Research & Design CorpOther Health CarePre-Seed$435K84%
Cagent Vascular, Inc.Other Health CareSeries B$213.4M84%
R3 Vascular Inc.Other Health CareSeries C$620.6M84%
PolyVascular, Inc.Other Health CarePre-Seed$5.6M84%
Frequently asked
How much funding has Scientia Vascular, Inc. raised?
Scientia Vascular, Inc. has raised approximately $55.0M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Scientia Vascular, Inc.'s estimated valuation?
Provath's modeled valuation for Scientia Vascular, Inc. is approximately $48.2M (modeled range $18.3M–$79.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Scientia Vascular, Inc. at?
Scientia Vascular, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Wed Nov 15.
What does Scientia Vascular, Inc. do and where is it based?
Scientia Vascular, Inc. operates in the Other Health Care sector, based in WEST VALLEY CITY.
Explore related

See where Scientia Vascular, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Scientia Vascular, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.